These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9376263)

  • 1. Induction of muscle protein degradation by a tumour factor.
    Lorite MJ; Cariuk P; Tisdale MJ
    Br J Cancer; 1997; 76(8):1035-40. PubMed ID: 9376263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of muscle protein degradation induced by a cancer cachectic factor.
    Lorite MJ; Thompson MG; Drake JL; Carling G; Tisdale MJ
    Br J Cancer; 1998 Oct; 78(7):850-6. PubMed ID: 9764574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexia.
    Smith KL; Tisdale MJ
    Br J Cancer; 1993 Apr; 67(4):680-5. PubMed ID: 8471425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of eicosapentaenoic acid, protein and amino acids on protein synthesis and degradation in skeletal muscle of cachectic mice.
    Smith HJ; Greenberg NA; Tisdale MJ
    Br J Cancer; 2004 Jul; 91(2):408-12. PubMed ID: 15213711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid.
    Whitehouse AS; Smith HJ; Drake JL; Tisdale MJ
    Cancer Res; 2001 May; 61(9):3604-9. PubMed ID: 11325828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of muscle protein degradation in cancer cachexia.
    Smith KL; Tisdale MJ
    Br J Cancer; 1993 Aug; 68(2):314-8. PubMed ID: 8347486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in nucleic acid and protein levels in atrophying skeletal muscle in cancer cachexia.
    Bhogal AS; Lorite ML; Tisdale MJ
    Anticancer Res; 2006; 26(6B):4149-54. PubMed ID: 17201126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of cachexia in mice by a product isolated from the urine of cachectic cancer patients.
    Cariuk P; Lorite MJ; Todorov PT; Field WN; Wigmore SJ; Tisdale MJ
    Br J Cancer; 1997; 76(5):606-13. PubMed ID: 9303359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of lipolysis and muscle protein degradation by EPA in cancer cachexia.
    Tisdale MJ
    Nutrition; 1996 Jan; 12(1 Suppl):S31-3. PubMed ID: 8850217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of muscle protein degradation and weight loss by a tumor product.
    Todorov PT; McDevitt TM; Cariuk P; Coles B; Deacon M; Tisdale MJ
    Cancer Res; 1996 Mar; 56(6):1256-61. PubMed ID: 8640810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of a proteolysis-inducing factor (PIF) in cachexia induced by a human melanoma (G361).
    Todorov PT; Field WN; Tisdale MJ
    Br J Cancer; 1999 Aug; 80(11):1734-7. PubMed ID: 10468289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased gene expression of brown fat uncoupling protein (UCP)1 and skeletal muscle UCP2 and UCP3 in MAC16-induced cancer cachexia.
    Bing C; Brown M; King P; Collins P; Tisdale MJ; Williams G
    Cancer Res; 2000 May; 60(9):2405-10. PubMed ID: 10811117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cleavage of caspases-1, -3, -6, -8 and -9 substrates by proteases in skeletal muscles from mice undergoing cancer cachexia.
    Belizário JE; Lorite MJ; Tisdale MJ
    Br J Cancer; 2001 Apr; 84(8):1135-40. PubMed ID: 11308266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of skeletal muscle atrophy in cancer cachexia by D-myo-inositol 1,2,6-triphosphate.
    Russell ST; Siren PM; Siren MJ; Tisdale MJ
    Cancer Chemother Pharmacol; 2009 Aug; 64(3):517-27. PubMed ID: 19112551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of weight loss induced by recombinant tumour necrosis factor with that produced by a cachexia-inducing tumour.
    Mahony SM; Beck SA; Tisdale MJ
    Br J Cancer; 1988 Apr; 57(4):385-9. PubMed ID: 3390373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the anticatabolic effects of leucine and Ca-β-hydroxy-β-methylbutyrate in experimental models of cancer cachexia.
    Mirza KA; Pereira SL; Voss AC; Tisdale MJ
    Nutrition; 2014; 30(7-8):807-13. PubMed ID: 24984997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of megestrol acetate on weight loss induced by tumour necrosis factor alpha and a cachexia-inducing tumour (MAC16) in NMRI mice.
    Beck SA; Tisdale MJ
    Br J Cancer; 1990 Sep; 62(3):420-4. PubMed ID: 2206950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological interference with tissue hypercatabolism in tumour-bearing rats.
    Tessitore L; Costelli P; Baccino FM
    Biochem J; 1994 Apr; 299 ( Pt 1)(Pt 1):71-8. PubMed ID: 8166661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a cachectic factor on carbohydrate metabolism and attenuation by eicosapentaenoic acid.
    Hussey HJ; Tisdale MJ
    Br J Cancer; 1999 Jun; 80(8):1231-5. PubMed ID: 10376976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a cancer cachectic factor.
    Todorov P; Cariuk P; McDevitt T; Coles B; Fearon K; Tisdale M
    Nature; 1996 Feb; 379(6567):739-42. PubMed ID: 8602222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.